These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 16427241)

  • 1. The first detection of CTX-M-14 extended-spectrum beta-lactamase among diverse beta-lactamase-producing Proteus mirabilis clinical isolates.
    Yong D; Lim YS; Roh KH; Choi YS; Park DY; Yum JH; Kim JM; Lee K; Chong Y
    Diagn Microbiol Infect Dis; 2006 Mar; 54(3):237-9. PubMed ID: 16427241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissemination of Proteus mirabilis isolates harboring CTX-M-14 and CTX-M-3 beta-lactamases at 2 hospitals in Taiwan.
    Wu LT; Wu HJ; Chung JG; Chuang YC; Cheng KC; Yu WL
    Diagn Microbiol Infect Dis; 2006 Feb; 54(2):89-94. PubMed ID: 16406185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapidly spreading CTX-M-type beta-lactamase-producing Proteus mirabilis in Japan.
    Kanayama A; Iyoda T; Matsuzaki K; Saika T; Ikeda F; Ishii Y; Yamaguchi K; Kobayashi I
    Int J Antimicrob Agents; 2010 Oct; 36(4):340-2. PubMed ID: 20609568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management.
    Luzzaro F; Brigante G; D'Andrea MM; Pini B; Giani T; Mantengoli E; Rossolini GM; Toniolo A
    Int J Antimicrob Agents; 2009 Apr; 33(4):328-33. PubMed ID: 19095415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of extended-spectrum beta-lactamases in Proteus mirabilis in a Taiwanese university hospital, 1999 to 2005: identification of a novel CTX-M enzyme (CTX-M-66).
    Wu JJ; Chen HM; Ko WC; Wu HM; Tsai SH; Yan JJ
    Diagn Microbiol Infect Dis; 2008 Feb; 60(2):169-75. PubMed ID: 17913434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular epidemiology and antimicrobial susceptibility of extended- and broad-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated in Portugal.
    Mendonça N; Ferreira E; Louro D; ; Caniça M
    Int J Antimicrob Agents; 2009 Jul; 34(1):29-37. PubMed ID: 19272757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005--the new 'MRSAs'?
    Damjanova I; Tóth A; Pászti J; Hajbel-Vékony G; Jakab M; Berta J; Milch H; Füzi M
    J Antimicrob Chemother; 2008 Nov; 62(5):978-85. PubMed ID: 18667450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissemination of the CTX-M-25 family beta-lactamases among Klebsiella pneumoniae, Escherichia coli and Enterobacter cloacae and identification of the novel enzyme CTX-M-41 in Proteus mirabilis in Israel.
    Navon-Venezia S; Chmelnitsky I; Leavitt A; Carmeli Y
    J Antimicrob Chemother; 2008 Aug; 62(2):289-95. PubMed ID: 18487232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interspecies spread of CTX-M-32 extended-spectrum beta-lactamase and the role of the insertion sequence IS1 in down-regulating bla CTX-M gene expression.
    Fernández A; Gil E; Cartelle M; Pérez A; Beceiro A; Mallo S; Tomás MM; Pérez-Llarena FJ; Villanueva R; Bou G
    J Antimicrob Chemother; 2007 May; 59(5):841-7. PubMed ID: 17332005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in beta-lactam-resistant Proteus mirabilis strains due to CTX-M- and CMY-type as well as new VEB- and inhibitor-resistant TEM-type beta-lactamases.
    Aragón LM; Mirelis B; Miró E; Mata C; Gómez L; Rivera A; Coll P; Navarro F
    J Antimicrob Chemother; 2008 May; 61(5):1029-32. PubMed ID: 18292096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nosocomial outbreak by Proteus mirabilis producing extended-spectrum beta-lactamase VEB-1 in a Korean university hospital.
    Kim JY; Park YJ; Kim SI; Kang MW; Lee SO; Lee KY
    J Antimicrob Chemother; 2004 Dec; 54(6):1144-7. PubMed ID: 15546971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEB-6 extended-spectrum beta-lactamase-producing Proteus mirabilis from Sultanate of Oman.
    Potron A; Poirel L; Elhag K; Al Yaqoubi F; Nordmann P
    Int J Antimicrob Agents; 2009 Nov; 34(5):493-4. PubMed ID: 19525094
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular epidemiology of CTX-M-type extended-spectrum β-lactamase-producing Proteus mirabilis isolates in Taiwan.
    Huang CW; Chien JH; Peng RY; Tsai DJ; Li MH; Lee HM; Lin CF; Lee MC; Liao CT
    Int J Antimicrob Agents; 2015 Jan; 45(1):84-5. PubMed ID: 25446905
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of CTX-M-15, CTX-M-22, and SHV-2 extended-spectrum beta-lactamases (ESBLs) in Escherichia coli fecal-sample isolates from pig farms in China.
    Tian GB; Wang HN; Zou LK; Tang JN; Zhao YW; Ye MY; Tang JY; Zhang Y; Zhang AY; Yang X; Xu CW; Fu YJ
    Foodborne Pathog Dis; 2009 Apr; 6(3):297-304. PubMed ID: 19272004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended-spectrum {beta}-lactamases and AmpC {beta}-lactamases in ceftiofur-resistant Salmonella enterica isolates from food and livestock obtained in Germany during 2003-07.
    Rodríguez I; Barownick W; Helmuth R; Mendoza MC; Rodicio MR; Schroeter A; Guerra B
    J Antimicrob Chemother; 2009 Aug; 64(2):301-9. PubMed ID: 19474065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence and molecular analysis of extended-spectrum {beta}-lactamase-producing Proteus mirabilis in Hong Kong, 1999-2002.
    Ho PL; Ho AY; Chow KH; Wong RC; Duan RS; Ho WL; Mak GC; Tsang KW; Yam WC; Yuen KY
    J Antimicrob Chemother; 2005 Jun; 55(6):840-5. PubMed ID: 15857942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTX-M-1 extended-spectrum beta-lactamase-producing Proteus mirabilis in Greece.
    Karapavlidou P; Sofianou D; Manolis EN; Pournaras S; Tsakris A
    Microb Drug Resist; 2005; 11(4):351-4. PubMed ID: 16359194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of Proteus mirabilis isolates producing TEM-52 extended-spectrum beta-lactamases in Croatia.
    Sardelić S; Bedenić B; Sijak D; Colinon C; Kalenić S
    Chemotherapy; 2010; 56(3):208-13. PubMed ID: 20551637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Ambler class A and D beta-lactamases among clinical isolates of Pseudomonas aeruginosa in Korea.
    Lee S; Park YJ; Kim M; Lee HK; Han K; Kang CS; Kang MW
    J Antimicrob Chemother; 2005 Jul; 56(1):122-7. PubMed ID: 15890715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbapenem-hydrolysing beta-lactamase KPC-2 in Klebsiella pneumoniae isolated in Rio de Janeiro, Brazil.
    Peirano G; Seki LM; Val Passos VL; Pinto MC; Guerra LR; Asensi MD
    J Antimicrob Chemother; 2009 Feb; 63(2):265-8. PubMed ID: 19028717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.